At the PTAB Blog
July 16, 2024
Never miss an Insight.
Sign upEvent
2024 @Philly Cell and Gene Therapy Annual Conference 2024 @Philly Cell and Gene Therapy Annual Conference
June 14-15, 2024
Philadelphia
Articles
Trending at the PTAB: Real Party in Interest and IPR Trending at the PTAB: Real Party in Interest and IPR
May 31, 2024
Law360Event
Biosimilars and Interchangeable Biologics: New FDA Draft Guidance Clarifying Application Process for Approval Biosimilars and Interchangeable Biologics: New FDA Draft Guidance Clarifying Application Process for Approval
November 28, 2023
Webinar
Event
Secondary Patents on Both Sides of the Pond: Impact of Clinical Trials on Patentability Secondary Patents on Both Sides of the Pond: Impact of Clinical Trials on Patentability
November 2, 2023
Webinar
Event
Patent Drafting for Multiple Jurisdictions Patent Drafting for Multiple Jurisdictions
October 11, 2023
Webinar
Event
Protecting Your Life Sciences Innovations: Challenges in the USA and Europe Protecting Your Life Sciences Innovations: Challenges in the USA and Europe
July 27, 2023
Taipei
Event
Biologics Price Competition and Innovation Act: Purple Book, Dispute Resolution, Exclusivities, and Court Treatment Biologics Price Competition and Innovation Act: Purple Book, Dispute Resolution, Exclusivities, and Court Treatment
January 5, 2023
Webinar
Event
2022 Chinese Biopharmaceutical Association Annual Conference-Maryland 2022 Chinese Biopharmaceutical Association Annual Conference-Maryland
December 17, 2022
Gaithersburg
At the PTAB Blog
References Cited in IDSs but Not Discussed by Examiners May Get Petitioners over the Hurdle of Institution Denial References Cited in IDSs but Not Discussed by Examiners May Get Petitioners over the Hurdle of Institution Denial
December 15, 2022
Articles
How New USPTO Guidance Fine-Tunes Fintiv Application How New USPTO Guidance Fine-Tunes Fintiv Application
July 14, 2022
Law360Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.